Vinorelbine structure
|
Common Name | Vinorelbine | ||
---|---|---|---|---|
CAS Number | 71486-22-1 | Molecular Weight | 778.932 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C45H54N4O8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of VinorelbineVinorelbine is an anti-mitotic agent which inhibits the proliferation of Hela cells with IC50 of 1.25 nM. |
Name | vinorelbine |
---|---|
Synonym | More Synonyms |
Description | Vinorelbine is an anti-mitotic agent which inhibits the proliferation of Hela cells with IC50 of 1.25 nM. |
---|---|
Related Catalog | |
In Vitro | Vinorelbine (0.5-5 nM) inhibits cell proliferation by 50% (IC50) at concentrations of 1.25 nM. At concentration of 8 nM vinorelbine, no cells are in anaphase[1]. Vinorelbine time-dependently induces the p53 and p21WAFI/CIP1 expression in androgen-dependent (AD) and- independent (AI) prostate cancer cell lines. Vinorelbine stimulates reporter genes in a concentration-dependent manner[2]. |
In Vivo | After vinorelbine treatment, the first neutropenicepisode occurred after the first (4 dogs), second (1), or sixth(1) vinorelbine treatment in the dogs[3]. Vinorelbine is tolerated at a weekly interval in tumor-bearing cats, with an MTD of 11.5 mg/m2[4]. |
Animal Admin | As defined by the study, VRL1 is diluted in 0.9% NaCl to a concentration of 1.5 mg/mL, and given IV over 5 minutes. The intended treatment interval is 7 days for up to 4 treatments. After receiving 4 weekly doses, cats are eligible to continue VRL treatment every 2 weeks at the owner's expense. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C45H54N4O8 |
Molecular Weight | 778.932 |
Exact Mass | 778.394165 |
PSA | 133.87000 |
LogP | 4.69 |
Index of Refraction | 1.676 |
Storage condition | 2-8C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
~79% Vinorelbine CAS#:71486-22-1 |
Literature: Gueritte; Pouilhes; Mangeney; et al. European Journal of Medicinal Chemistry, 1983 , vol. 18, # 5 p. 419 - 424 |
~77% Vinorelbine CAS#:71486-22-1 |
Literature: Gueritte; Pouilhes; Mangeney; et al. European Journal of Medicinal Chemistry, 1983 , vol. 18, # 5 p. 419 - 424 |
~76% Vinorelbine CAS#:71486-22-1 |
Literature: European Journal of Medicinal Chemistry, , vol. 18, # 5 p. 419 - 424 |
~% Vinorelbine CAS#:71486-22-1 |
Literature: European Journal of Medicinal Chemistry, , vol. 18, # 5 p. 419 - 424 |
Precursor 1 | |
---|---|
DownStream 1 | |
Methyl (2β,3β,4β,5α,12β,19α)-4-acetoxy-15-[(12S)-16-ethyl-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.0.0]octadeca-3(11),4,6,8,15-pentaen-12-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate |
8-methylsulfanyl-5-nonylsulfanyl-quinoline |
aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2β,3β,4β,5α,12β,19α)- |
vinorebline |
3',4'-didehydro-4'-desoxy-8'-norvincaleucoblastine |
5-Nonylthio-8-methylthio-chinolin |
5'-noranhydrovinblastine |
vinorelbene |
Methyl (2β,3β,4β,5α,12β,19α)-4-acetoxy-15-[(12S)-16-ethyl-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.0.0]octadeca-3(11),4,6,8,15-pentaen-12-yl]-3-hydroxy-16-methox y-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate |
Quinoline,8-(methylthio)-5-(nonylthio) |
Vinorelbine |
Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-[(8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-, meth ;yl ester, (2β,3β,4β,5α,12β,19α)- |